Company Filing History:
Years Active: 2019
Title: Rolf Schuetz: Innovator in MMP-12 Inhibition
Introduction
Rolf Schuetz is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of pharmaceutical and cosmetic compositions through his innovative work. His research focuses on developing compounds that can selectively inhibit Matrix Metalloprotease-12 (MMP-12), which is crucial for various medical applications.
Latest Patents
Rolf Schuetz holds a patent for "Phosphinic peptide derivatives for use as MMP-12 inhibitors." This invention relates to compounds that serve as selective inhibitors of MMP-12. The patent outlines the use of these compounds in cosmetic and pharmaceutical compositions, aimed at preventing and treating ailments associated with MMP-12. His work in this area is groundbreaking and has the potential to impact various therapeutic approaches.
Career Highlights
Throughout his career, Rolf Schuetz has been associated with Dsm IP Assets B.V., where he has furthered his research and development efforts. His expertise in the field of peptide derivatives has positioned him as a key figure in the innovation of MMP-12 inhibitors.
Collaborations
Rolf has collaborated with talented individuals such as Stéphanie Boudon and Eileen Jackson. These partnerships have enhanced his research capabilities and contributed to the success of his projects.
Conclusion
Rolf Schuetz is a distinguished inventor whose work on MMP-12 inhibitors showcases his commitment to advancing pharmaceutical and cosmetic sciences. His innovative contributions continue to pave the way for new treatments and applications in the industry.